Tirzepatide, liraglutide, and next-generation GLP-1s follow, addressing differentiated efficacy and metabolic profiles
These can include nausea, vomiting of undigested food, abdominal pain, bloating, severe dehydration, a sense of fullness after only a few bites, solidification of undigested food within the stomach, acid reflux, fluctuating blood sugar readings, reduced appetite, weight loss, undernutrition, and a diminished overall quality of life
Gastrointestinal side effects (like nausea, vomiting, and diarrhea) are very common
PlexusDx Semaglutide Injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) delivers the same active ingredient studied in the SUSTAIN and SELECT trials, activating GLP-1 pathways that metformin simply does not reach